Donor: Aids Fonds – STOP AIDS NOW
Geography: All of Ukraine
Implementation Period: July 1, 2022 – June 30, 2025
Key Achievements:
- National Intellectual Property Development Strategy until 2030
A dedicated section on “Intellectual Property and Pharmaceuticals” was developed with expert support from staff and consultants.
This strategy is considered the most patient-centered in the history of intellectual property strategies in Ukraine.
Proposals for the Draft Rules on Patent Application Examination for Inventions and Utility Models
- Developed by staff and consultants.
- Incorporated into the official Rules approved by the Ministry of Economy Order No. 23301 dated September 9, 2024.
- Require consideration of significant therapeutic effect changes when patenting new forms of known medicines.
- Aimed at improving patent examination quality and combating the practice of #stopevergreeningpatents.
Patent Oppositions on Rilpivirine:
- Opposition 1: Use of rilpivirine or its pharmaceutically acceptable salt in combination with hyaluronidase for the treatment or prevention of HIV infection.
- Opposition 2: Pediatric formulation of rilpivirine.